董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kwong Yeow Liew | 男 | Director | 70 | 未披露 | 0.30 | 2026-04-28 |
| Alfred Lim | 男 | Chief Executive Officer and Executive Director | 74 | 未披露 | 5.37 | 2026-04-28 |
| Bo Huang | 男 | Director | 36 | 未披露 | 未持股 | 2026-04-28 |
| Chern Yong Lew | 男 | Chairman of the Board and Director | 52 | 未披露 | 未持股 | 2026-04-28 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Alfred Lim | 男 | Chief Executive Officer and Executive Director | 74 | 未披露 | 5.37 | 2026-04-28 |
| Whye Shin Tay | 女 | Interim Chief Financial Officer | 40 | 未披露 | 未持股 | 2026-04-28 |
董事简历
中英对照 | 中文 | 英文- Kwong Yeow Liew
-
Kwong Yeow Liew自2017年11月以来一直担任我们的董事。Liew先生在多个跨国组织拥有超过25年的经验，例如松下电机（Matsushita Denki），通用汽车（General Motors），英特尔（Intel）以及Urmet Telecoms Italy。他于2014年3月至2016年8月担任Moxian，Inc.的董事。Liew从2013年2月到2015年1月担任Rebel Group，Inc.（一家新加坡公司）总裁、首席执行官和董事。Liew先生在2006年帮助Urmet Telecommunications S.p.A在中国建立了第一个制造工厂，并对其供应链进行了微调。在此之前，Liew从2001年到2005年担任Aztech Singapore Pte Ltd&8217；s中国工厂总经理。从1992年到2001年，他曾担任Phoenix Mecano S e Asia Pte Ltd（位于新加坡）的制造设施的运营主管。Liew先生于1974年获得Singapore Technical Education的电气工程证书。他还于1974年在Moe Singapore（1976年在Matsushita Denki Management Development Program（1978年））、1983年在General Motors Institute（1983年）和1987年在Intel University（1987年）完成了有关电气和电子的城市和行会的管理研究课程。刘先生英语和汉语都很流利。
Kwong Yeow Liew is Euda Health Holdings Limited's independent director who has more than 25 years of experience in several multi national organizations, such as Matsushita Denki, General Motors, Intel as well as Urmet Telecoms Italy. He served as a Director 8i Enterprises Acquisition Corp., a blank check company listed on Nasdaq, from March 2018 until September 2020 when it consummated its business combination with Diginex Ltd, and of Moxian, Inc. from March 2014 to August 2016. Mr. Liew served as the President, Chief Executive Officer and director of Rebel Group, Inc., a Singapore company, from February 2013 to January 2015. In 2006, Mr. Liew was instrumental in setting up the first manufacturing plant of Urmet Telecommunications S.p.A in China and fine tuning its supply chain. Prior to that, Mr. Liew was the General Manager of Aztech Singapore Pte. Ltd's plant in China from 2001 through 2005. From 1992 through 2001, he served as the Head of Operations of the manufacturing facilities of Phoenix Mecano S E Asia Pte. Ltd in Singapore. Mr. Liew received his certificate in Electrical Engineering from Singapore Technical Education in 1974. He also completed the management study programs in City and Guilds regarding Electrical and Electronics in 1974, Industrial Training Board at MOE Singapore in 1976, Matsushita DENKI Management Development Program in 1978, General Motors Institute in 1983 and Intel University in 1987. Mr. Liew is fluent in English and Chinese. - Kwong Yeow Liew自2017年11月以来一直担任我们的董事。Liew先生在多个跨国组织拥有超过25年的经验，例如松下电机（Matsushita Denki），通用汽车（General Motors），英特尔（Intel）以及Urmet Telecoms Italy。他于2014年3月至2016年8月担任Moxian，Inc.的董事。Liew从2013年2月到2015年1月担任Rebel Group，Inc.（一家新加坡公司）总裁、首席执行官和董事。Liew先生在2006年帮助Urmet Telecommunications S.p.A在中国建立了第一个制造工厂，并对其供应链进行了微调。在此之前，Liew从2001年到2005年担任Aztech Singapore Pte Ltd&8217；s中国工厂总经理。从1992年到2001年，他曾担任Phoenix Mecano S e Asia Pte Ltd（位于新加坡）的制造设施的运营主管。Liew先生于1974年获得Singapore Technical Education的电气工程证书。他还于1974年在Moe Singapore（1976年在Matsushita Denki Management Development Program（1978年））、1983年在General Motors Institute（1983年）和1987年在Intel University（1987年）完成了有关电气和电子的城市和行会的管理研究课程。刘先生英语和汉语都很流利。
- Kwong Yeow Liew is Euda Health Holdings Limited's independent director who has more than 25 years of experience in several multi national organizations, such as Matsushita Denki, General Motors, Intel as well as Urmet Telecoms Italy. He served as a Director 8i Enterprises Acquisition Corp., a blank check company listed on Nasdaq, from March 2018 until September 2020 when it consummated its business combination with Diginex Ltd, and of Moxian, Inc. from March 2014 to August 2016. Mr. Liew served as the President, Chief Executive Officer and director of Rebel Group, Inc., a Singapore company, from February 2013 to January 2015. In 2006, Mr. Liew was instrumental in setting up the first manufacturing plant of Urmet Telecommunications S.p.A in China and fine tuning its supply chain. Prior to that, Mr. Liew was the General Manager of Aztech Singapore Pte. Ltd's plant in China from 2001 through 2005. From 1992 through 2001, he served as the Head of Operations of the manufacturing facilities of Phoenix Mecano S E Asia Pte. Ltd in Singapore. Mr. Liew received his certificate in Electrical Engineering from Singapore Technical Education in 1974. He also completed the management study programs in City and Guilds regarding Electrical and Electronics in 1974, Industrial Training Board at MOE Singapore in 1976, Matsushita DENKI Management Development Program in 1978, General Motors Institute in 1983 and Intel University in 1987. Mr. Liew is fluent in English and Chinese.
- Alfred Lim
-
Alfred Lim于1978年在欧洲顶级化学品和制药公司之一的May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd开始了他的职业生涯，之后于1990年进入Neste Chemicals Trading Singapore Pte Ltd，担任董事总经理，负责向美国、欧洲和亚洲的公司销售和营销。1994年至2002年间，他担任北欧化工新加坡私人有限公司董事总经理，管理该公司的亚太办事处和分销商。在林先生的职权范围内，新加坡北欧化工荣获1998/1999年度财政部颁发的国际贸易奖、贸易和工业部颁发的认可国际交易商地位和新加坡股东基金最高回报1000强。2002年，Lim与他人共同创立了马来西亚化学品分销商Akashi Sdn Bhd，该公司后来被出售给East Asiatic Chemicals/Brenntag。从2006年到2018年，林先生担任安阳集团的高级顾问，在越南为国际卫浴产品品牌建立了分销网络。自2018年以来，他一直担任全球最大的越南卫浴制造商乐家集团的顾问。Alfred于1976年在新加坡大学获得化学理学士（荣誉）学位，1986年在新加坡管理学院获得市场营销研究生文凭。
Alfred Lim is Euda Health Holdings Limited's Executive Director and has started serving as Euda Health Holdings Limited's Chief Executive Officer since February 2025. Mr. Lim has over 44 years of experience in international trade business, covering the Asia Pacific region. He started his career in 1978 with May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd, one of Europe's top chemicals and pharmaceutical companies, before moving on to Neste Chemicals Trading Singapore Pte Ltd in 1990, where he was the Managing Director responsible for sales and marketing to companies in United States, Europe, and Asia. Between 1994 to 2002, he was the managing director of Borealis Singapore Pte Ltd, managing the company's Asia Pacific offices and distributors. Under Mr. Lim's remit, Borealis Singapore was awarded the International Trade Award from Ministry of Finance, Approved International Trader status from Ministry of Trade & Industry and Singapore 1,000 Ranking for Highest Returns on Shareholders' Funds for year 1998/1999. In 2002, Mr Lim co founded Akashi Sdn Bhd, a Malaysian distributor for chemicals which was later sold to East Asiatic Chemicals/Brenntag. From 2006 to 2018, Mr. Lim acted as a senior consultant to An Duong Group, setting up a distributor network in Vietnam for international bathroom product brands. Since 2018, he has been a consultant to Roca Group, the world's largest sanitary ware manufacturer for Vietnam. Alfred received his Bachelor of Science (Honors) degree in Chemistry from the University of Singapore in 1976, Graduate diploma in Marketing from Singapore Institute of Management in 1986. - Alfred Lim于1978年在欧洲顶级化学品和制药公司之一的May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd开始了他的职业生涯，之后于1990年进入Neste Chemicals Trading Singapore Pte Ltd，担任董事总经理，负责向美国、欧洲和亚洲的公司销售和营销。1994年至2002年间，他担任北欧化工新加坡私人有限公司董事总经理，管理该公司的亚太办事处和分销商。在林先生的职权范围内，新加坡北欧化工荣获1998/1999年度财政部颁发的国际贸易奖、贸易和工业部颁发的认可国际交易商地位和新加坡股东基金最高回报1000强。2002年，Lim与他人共同创立了马来西亚化学品分销商Akashi Sdn Bhd，该公司后来被出售给East Asiatic Chemicals/Brenntag。从2006年到2018年，林先生担任安阳集团的高级顾问，在越南为国际卫浴产品品牌建立了分销网络。自2018年以来，他一直担任全球最大的越南卫浴制造商乐家集团的顾问。Alfred于1976年在新加坡大学获得化学理学士（荣誉）学位，1986年在新加坡管理学院获得市场营销研究生文凭。
- Alfred Lim is Euda Health Holdings Limited's Executive Director and has started serving as Euda Health Holdings Limited's Chief Executive Officer since February 2025. Mr. Lim has over 44 years of experience in international trade business, covering the Asia Pacific region. He started his career in 1978 with May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd, one of Europe's top chemicals and pharmaceutical companies, before moving on to Neste Chemicals Trading Singapore Pte Ltd in 1990, where he was the Managing Director responsible for sales and marketing to companies in United States, Europe, and Asia. Between 1994 to 2002, he was the managing director of Borealis Singapore Pte Ltd, managing the company's Asia Pacific offices and distributors. Under Mr. Lim's remit, Borealis Singapore was awarded the International Trade Award from Ministry of Finance, Approved International Trader status from Ministry of Trade & Industry and Singapore 1,000 Ranking for Highest Returns on Shareholders' Funds for year 1998/1999. In 2002, Mr Lim co founded Akashi Sdn Bhd, a Malaysian distributor for chemicals which was later sold to East Asiatic Chemicals/Brenntag. From 2006 to 2018, Mr. Lim acted as a senior consultant to An Duong Group, setting up a distributor network in Vietnam for international bathroom product brands. Since 2018, he has been a consultant to Roca Group, the world's largest sanitary ware manufacturer for Vietnam. Alfred received his Bachelor of Science (Honors) degree in Chemistry from the University of Singapore in 1976, Graduate diploma in Marketing from Singapore Institute of Management in 1986.
- Bo Huang
-
黄波是深圳市钥匙锁生物技术有限公司的总经理。在加入深圳市钥匙锁生物技术有限公司之前，黄先生曾担任深圳市可威机器人技术有限公司的城市经理，该职位于2020年3月至2024年6月担任。2016年10月至2019年7月，黄先生担任深圳市喜喜网络科技有限公司项目经理，2013年3月至2016年9月，黄先生担任纳斯达克上市公司幻线科技（深圳）有限公司深圳市场运营总监。黄先生于2009年7月获得郑州工业大学学士学位。
Bo Huang is the General Manager of Shenzhen Key Lock Biotechnology Co., Ltd. Prior to Shenzhen Key Lock Biotechnology Co., Ltd., Mr. Huang served as City Manager of Shenzhen Kewei Robotics Technology Co., Ltd., a position he held from March 2020 to June 2024. From October 2016 to July 2019, Mr. Huang served as Project Manager of Shenzhen Xixi Network Technology Co., Ltd., and from March 2013 to September 2016, Mr. Huang served as Shenzhen Market Operations Director of Magic Line Technology (Shenzhen) Co., Ltd., a NASDAQ listed company. Mr. Huang has earned a Bachelor's Degree from Zhengzhou University of Technology in July 2009. - 黄波是深圳市钥匙锁生物技术有限公司的总经理。在加入深圳市钥匙锁生物技术有限公司之前，黄先生曾担任深圳市可威机器人技术有限公司的城市经理，该职位于2020年3月至2024年6月担任。2016年10月至2019年7月，黄先生担任深圳市喜喜网络科技有限公司项目经理，2013年3月至2016年9月，黄先生担任纳斯达克上市公司幻线科技（深圳）有限公司深圳市场运营总监。黄先生于2009年7月获得郑州工业大学学士学位。
- Bo Huang is the General Manager of Shenzhen Key Lock Biotechnology Co., Ltd. Prior to Shenzhen Key Lock Biotechnology Co., Ltd., Mr. Huang served as City Manager of Shenzhen Kewei Robotics Technology Co., Ltd., a position he held from March 2020 to June 2024. From October 2016 to July 2019, Mr. Huang served as Project Manager of Shenzhen Xixi Network Technology Co., Ltd., and from March 2013 to September 2016, Mr. Huang served as Shenzhen Market Operations Director of Magic Line Technology (Shenzhen) Co., Ltd., a NASDAQ listed company. Mr. Huang has earned a Bachelor's Degree from Zhengzhou University of Technology in July 2009.
- Chern Yong Lew
-
陈永强是EUDA Health Holdings Limited的独立董事，拥有超过25年的商业经验。Lew先生的职业生涯始于毕马威会计师事务所（KPMG LLP）近3年的审计师，之后他加入Wong Fong Industries Ltd，在该公司担任了16年的执行董事，并一直担任董事会成员。他于2019年3月至2022年7月担任Y Ventures Group Ltd的执行董事长，其职责是推动电子商务集团的战略方向和增长，并为管理层提供指导。卢先生自2023年1月以来一直担任Eggriculture Foods Ltd的董事会成员。他还担任WMRAS（新加坡美国废物管理和回收协会）执行委员会董事会、NorthLight School董事会、南大南洋商学院校友委员会成员。2016年，卢先生因其对新加坡中小型实体（SMEs）和创新的贡献，被提名为海峡时报年度新加坡人。Lew先生拥有新加坡南洋理工大学会计学士学位，辅修银行和金融。
Chern Yong Lew is Euda Health Holdings Limited's independent director who has over 25 years of business experience. Mr. Lew started his career as an auditor with KPMG LLP for nearly 3 years before joining Wong Fong Industries Ltd where he served for 16 years as the Executive Director and remains as a board member. He served as the Executive Chairman of Y Ventures Group Ltd from March 2019 to July 2022, where his role was to drive the e commerce group's strategic direction and growth and to provide mentorship to management. Mr. Lew has served on the board of Eggriculture Foods Ltd since January 2023. He also serves on Executive Committee Board of WMRAS (Waste Management and Recycle Association of Singapore), the Board of Directors of Northlight School, and the NTU Nanyang Business School Alumni Board. In 2016, Mr. Lew was nominated for the Straits Times' Singaporean of the Year for his contribution to small and medium sized entities (SMEs) and innovation in Singapore. Mr. Lew has a Bachelor's Degree in Accountancy with a Minor in Banking and Finance from the Nanyang Technological University of Singapore. - 陈永强是EUDA Health Holdings Limited的独立董事，拥有超过25年的商业经验。Lew先生的职业生涯始于毕马威会计师事务所（KPMG LLP）近3年的审计师，之后他加入Wong Fong Industries Ltd，在该公司担任了16年的执行董事，并一直担任董事会成员。他于2019年3月至2022年7月担任Y Ventures Group Ltd的执行董事长，其职责是推动电子商务集团的战略方向和增长，并为管理层提供指导。卢先生自2023年1月以来一直担任Eggriculture Foods Ltd的董事会成员。他还担任WMRAS（新加坡美国废物管理和回收协会）执行委员会董事会、NorthLight School董事会、南大南洋商学院校友委员会成员。2016年，卢先生因其对新加坡中小型实体（SMEs）和创新的贡献，被提名为海峡时报年度新加坡人。Lew先生拥有新加坡南洋理工大学会计学士学位，辅修银行和金融。
- Chern Yong Lew is Euda Health Holdings Limited's independent director who has over 25 years of business experience. Mr. Lew started his career as an auditor with KPMG LLP for nearly 3 years before joining Wong Fong Industries Ltd where he served for 16 years as the Executive Director and remains as a board member. He served as the Executive Chairman of Y Ventures Group Ltd from March 2019 to July 2022, where his role was to drive the e commerce group's strategic direction and growth and to provide mentorship to management. Mr. Lew has served on the board of Eggriculture Foods Ltd since January 2023. He also serves on Executive Committee Board of WMRAS (Waste Management and Recycle Association of Singapore), the Board of Directors of Northlight School, and the NTU Nanyang Business School Alumni Board. In 2016, Mr. Lew was nominated for the Straits Times' Singaporean of the Year for his contribution to small and medium sized entities (SMEs) and innovation in Singapore. Mr. Lew has a Bachelor's Degree in Accountancy with a Minor in Banking and Finance from the Nanyang Technological University of Singapore.
高管简历
中英对照 | 中文 | 英文- Alfred Lim
Alfred Lim于1978年在欧洲顶级化学品和制药公司之一的May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd开始了他的职业生涯，之后于1990年进入Neste Chemicals Trading Singapore Pte Ltd，担任董事总经理，负责向美国、欧洲和亚洲的公司销售和营销。1994年至2002年间，他担任北欧化工新加坡私人有限公司董事总经理，管理该公司的亚太办事处和分销商。在林先生的职权范围内，新加坡北欧化工荣获1998/1999年度财政部颁发的国际贸易奖、贸易和工业部颁发的认可国际交易商地位和新加坡股东基金最高回报1000强。2002年，Lim与他人共同创立了马来西亚化学品分销商Akashi Sdn Bhd，该公司后来被出售给East Asiatic Chemicals/Brenntag。从2006年到2018年，林先生担任安阳集团的高级顾问，在越南为国际卫浴产品品牌建立了分销网络。自2018年以来，他一直担任全球最大的越南卫浴制造商乐家集团的顾问。Alfred于1976年在新加坡大学获得化学理学士（荣誉）学位，1986年在新加坡管理学院获得市场营销研究生文凭。
Alfred Lim is Euda Health Holdings Limited's Executive Director and has started serving as Euda Health Holdings Limited's Chief Executive Officer since February 2025. Mr. Lim has over 44 years of experience in international trade business, covering the Asia Pacific region. He started his career in 1978 with May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd, one of Europe's top chemicals and pharmaceutical companies, before moving on to Neste Chemicals Trading Singapore Pte Ltd in 1990, where he was the Managing Director responsible for sales and marketing to companies in United States, Europe, and Asia. Between 1994 to 2002, he was the managing director of Borealis Singapore Pte Ltd, managing the company's Asia Pacific offices and distributors. Under Mr. Lim's remit, Borealis Singapore was awarded the International Trade Award from Ministry of Finance, Approved International Trader status from Ministry of Trade & Industry and Singapore 1,000 Ranking for Highest Returns on Shareholders' Funds for year 1998/1999. In 2002, Mr Lim co founded Akashi Sdn Bhd, a Malaysian distributor for chemicals which was later sold to East Asiatic Chemicals/Brenntag. From 2006 to 2018, Mr. Lim acted as a senior consultant to An Duong Group, setting up a distributor network in Vietnam for international bathroom product brands. Since 2018, he has been a consultant to Roca Group, the world's largest sanitary ware manufacturer for Vietnam. Alfred received his Bachelor of Science (Honors) degree in Chemistry from the University of Singapore in 1976, Graduate diploma in Marketing from Singapore Institute of Management in 1986.- Alfred Lim于1978年在欧洲顶级化学品和制药公司之一的May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd开始了他的职业生涯，之后于1990年进入Neste Chemicals Trading Singapore Pte Ltd，担任董事总经理，负责向美国、欧洲和亚洲的公司销售和营销。1994年至2002年间，他担任北欧化工新加坡私人有限公司董事总经理，管理该公司的亚太办事处和分销商。在林先生的职权范围内，新加坡北欧化工荣获1998/1999年度财政部颁发的国际贸易奖、贸易和工业部颁发的认可国际交易商地位和新加坡股东基金最高回报1000强。2002年，Lim与他人共同创立了马来西亚化学品分销商Akashi Sdn Bhd，该公司后来被出售给East Asiatic Chemicals/Brenntag。从2006年到2018年，林先生担任安阳集团的高级顾问，在越南为国际卫浴产品品牌建立了分销网络。自2018年以来，他一直担任全球最大的越南卫浴制造商乐家集团的顾问。Alfred于1976年在新加坡大学获得化学理学士（荣誉）学位，1986年在新加坡管理学院获得市场营销研究生文凭。
- Alfred Lim is Euda Health Holdings Limited's Executive Director and has started serving as Euda Health Holdings Limited's Chief Executive Officer since February 2025. Mr. Lim has over 44 years of experience in international trade business, covering the Asia Pacific region. He started his career in 1978 with May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd, one of Europe's top chemicals and pharmaceutical companies, before moving on to Neste Chemicals Trading Singapore Pte Ltd in 1990, where he was the Managing Director responsible for sales and marketing to companies in United States, Europe, and Asia. Between 1994 to 2002, he was the managing director of Borealis Singapore Pte Ltd, managing the company's Asia Pacific offices and distributors. Under Mr. Lim's remit, Borealis Singapore was awarded the International Trade Award from Ministry of Finance, Approved International Trader status from Ministry of Trade & Industry and Singapore 1,000 Ranking for Highest Returns on Shareholders' Funds for year 1998/1999. In 2002, Mr Lim co founded Akashi Sdn Bhd, a Malaysian distributor for chemicals which was later sold to East Asiatic Chemicals/Brenntag. From 2006 to 2018, Mr. Lim acted as a senior consultant to An Duong Group, setting up a distributor network in Vietnam for international bathroom product brands. Since 2018, he has been a consultant to Roca Group, the world's largest sanitary ware manufacturer for Vietnam. Alfred received his Bachelor of Science (Honors) degree in Chemistry from the University of Singapore in 1976, Graduate diploma in Marketing from Singapore Institute of Management in 1986.
- Whye Shin Tay
Whye Shin Tay自2024年9月起担任Euda Health Holdings Limited的临时首席财务官。她目前也是8i Enterprises Pte.Ltd.（“8i Enterprises”）的客户总监，其中Meng Dong（James）Tan先生（“James Tan先生”）是其唯一的股东和董事。James Tan先生是重要股东，持有Euda Health Holdings Limited约17.8%的已发行普通股。自2021年11月以来，Tay女士一直负责管理8i Enterprises的投资组合公司。Tay女士在外部审计方面有着扎实的背景。2018年3月至2019年9月，她在国富浩华First Trust有限责任公司担任审计经理，2010年7月至2016年12月，在德勤会计师事务所担任审计经理，领导新加坡交易所上市公司、跨国公司和中小型企业的审计工作，涵盖制造、航运、广告和建筑等行业。Tay女士在马来西亚多媒体大学获得会计学学士学位，是新加坡特许会计师以及特许公认会计师公会资深会员。
Whye Shin Tay has been serving as Euda Health Holdings Limited's Interim Chief Financial Officer since September 2024. She is also currently the Accounts Director at 8i Enterprises Pte. Ltd. ("8i Enterprises") of which Mr. Meng Dong (James) Tan ("Mr. James Tan") is the sole shareholder and director. Mr. James Tan is a significant shareholder, holding approximately 17.8% of Euda Health Holdings Limited's outstanding ordinary shares. Since November 2021, Ms. Tay has been responsible for managing 8i Enterprises' portfolio companies. Ms. Tay has a solid background in external auditing. From March 2018 to September 2019, she was an Audit Manager at Crowe Horwath First Trust LLP, and from July 2010 to December 2016, an Audit Manager at Deloitte & Touche LLP, where she led audits for Singapore Exchange listed firms, multinational corporations, and small and medium sized enterprises across industries such as, manufacturing, shipping, advertising, and construction. Ms. Tay earned her bachelor's degree in accounting from Multimedia University, Malaysia, and is a Chartered Accountant of Singapore as well as a Fellow Member of the Association of Chartered Certified Accountants.- Whye Shin Tay自2024年9月起担任Euda Health Holdings Limited的临时首席财务官。她目前也是8i Enterprises Pte.Ltd.（“8i Enterprises”）的客户总监，其中Meng Dong（James）Tan先生（“James Tan先生”）是其唯一的股东和董事。James Tan先生是重要股东，持有Euda Health Holdings Limited约17.8%的已发行普通股。自2021年11月以来，Tay女士一直负责管理8i Enterprises的投资组合公司。Tay女士在外部审计方面有着扎实的背景。2018年3月至2019年9月，她在国富浩华First Trust有限责任公司担任审计经理，2010年7月至2016年12月，在德勤会计师事务所担任审计经理，领导新加坡交易所上市公司、跨国公司和中小型企业的审计工作，涵盖制造、航运、广告和建筑等行业。Tay女士在马来西亚多媒体大学获得会计学学士学位，是新加坡特许会计师以及特许公认会计师公会资深会员。
- Whye Shin Tay has been serving as Euda Health Holdings Limited's Interim Chief Financial Officer since September 2024. She is also currently the Accounts Director at 8i Enterprises Pte. Ltd. ("8i Enterprises") of which Mr. Meng Dong (James) Tan ("Mr. James Tan") is the sole shareholder and director. Mr. James Tan is a significant shareholder, holding approximately 17.8% of Euda Health Holdings Limited's outstanding ordinary shares. Since November 2021, Ms. Tay has been responsible for managing 8i Enterprises' portfolio companies. Ms. Tay has a solid background in external auditing. From March 2018 to September 2019, she was an Audit Manager at Crowe Horwath First Trust LLP, and from July 2010 to December 2016, an Audit Manager at Deloitte & Touche LLP, where she led audits for Singapore Exchange listed firms, multinational corporations, and small and medium sized enterprises across industries such as, manufacturing, shipping, advertising, and construction. Ms. Tay earned her bachelor's degree in accounting from Multimedia University, Malaysia, and is a Chartered Accountant of Singapore as well as a Fellow Member of the Association of Chartered Certified Accountants.